skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Journal Title: Gynecologic Oncology remove language: Norwegian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical significance of L1CAM expression in metastatic tubo-ovarian high-grade serous carcinoma
Material Type:
Article
Add to My Research

Clinical significance of L1CAM expression in metastatic tubo-ovarian high-grade serous carcinoma

Gynecologic oncology, 2023-09 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;ISSN: 0090-8258 ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.07.004

Digital Resources/Online E-Resources

2
Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience
Material Type:
Article
Add to My Research

Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience

Gynecologic oncology, 2021-08 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;ISSN: 0090-8258 ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2021.05.028

Digital Resources/Online E-Resources

3
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification
Material Type:
Article
Add to My Research

Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification

Gynecologic oncology, 2022-05, Vol.165 (2), p.230 [Peer Reviewed Journal]

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 0090-8258 ;ISSN: 1095-6859 ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2022.02.024 ;PMID: 35277281

Digital Resources/Online E-Resources

4
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
Material Type:
Article
Add to My Research

Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study

Gynecologic oncology, 2023-12, Vol.179, p.52 [Peer Reviewed Journal]

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 0090-8258 ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.10.012 ;PMID: 37924595

Digital Resources/Online E-Resources

5
Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study
Material Type:
Article
Add to My Research

Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study

Gynecologic oncology, 2023-08, Vol.175, p.72 [Peer Reviewed Journal]

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 0090-8258 ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2023.05.070 ;PMID: 37327542

Digital Resources/Online E-Resources

6
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
Material Type:
Article
Add to My Research

Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis

Gynecologic oncology, 2022-03, Vol.164 (3), p.498 [Peer Reviewed Journal]

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 0090-8258 ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2021.12.025 ;PMID: 35063276

Digital Resources/Online E-Resources

7
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma
Material Type:
Article
Add to My Research

SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma

Gynecologic oncology, 2019-06, Vol.153 (3), p.651 [Peer Reviewed Journal]

Copyright © 2019 Elsevier Inc. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 0090-8258 ;EISSN: 1095-6859 ;DOI: 10.1016/j.ygyno.2019.03.099 ;PMID: 30904337

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Searching Remote Databases, Please Wait